secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vaxcyte, Inc. (PCVX)
CIK:        0001649094
Form:       8-K
Filed at:   2024-09-06T23:59:59+00:00
Accession:  0001193125-24-214711
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaxcyte raises $1.42B in underwritten public offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Sold 10,194,175 shares at $103.00/share and pre-funded warrants to purchase 2,427,184 shares at $102.999/warrant.
- Underwriters' 30-day option for additional 1,893,203 shares exercised in full.
- Net proceeds expected to be approximately $1.42 billion after discounts and expenses.
- Closing expected on or about September 6, 2024, subject to customary conditions.
- Offering made under effective shelf registration statement (Form S-3).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649094/000119312524214711/0001193125-24-214711-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649094/000119312524214711/d802914d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-214711

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer